Avenue Biosciences is a transatlantic biotech business that specializes on innovative protein engineering technologies.
Avenue Biosciences has raised $7.4M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
Avenue Biosciences's investors include Dimerent, Tesi, Inventure, Voima Ventures, Balnord.
Avenue Biosciences is headquartered in Palo Alto, United States.
Avenue Biosciences is a transatlantic biotech business that specializes on innovative protein engineering technologies.
Avenue Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avenue Biosciences — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/avenue-biosciences. Accessed October 29, 2026.
VCBacked. (2026). Avenue Biosciences — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/avenue-biosciences
{{cite web |title=Avenue Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/avenue-biosciences |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated